A phase III randomised trial of LV5FU2 + irinotecan versus LV5FU2 alone in adjuvant high-risk colon cancer (FNCLCC Accord02/FFCD9802). (Q46140700)
Jump to navigation
Jump to search
scientific article published on 29 January 2009
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A phase III randomised trial of LV5FU2 + irinotecan versus LV5FU2 alone in adjuvant high-risk colon cancer (FNCLCC Accord02/FFCD9802). |
scientific article published on 29 January 2009 |
Statements
1 reference
A phase III randomised trial of LV5FU2 + irinotecan versus LV5FU2 alone in adjuvant high-risk colon cancer (FNCLCC Accord02/FFCD9802). (English)
1 reference
J-L Raoul
1 reference
J-Y Douillard
1 reference
S Gourgou-Bourgade
1 reference
R Bugat
1 reference
L Mineur
1 reference
F Viret
1 reference
Y Becouarn
1 reference
O Bouché
1 reference
E Gamelin
1 reference
M Ducreux
1 reference
T Conroy
1 reference
J-F Seitz
1 reference
L Bedenne
1 reference
A Kramar
1 reference
29 January 2009
1 reference
1 reference
20
1 reference
4
1 reference
674-680
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference